Kodak CEO Says Moving Forward On Generic Drug Ingredients Venture, With or Without Federal Loan
Eastman Kodak Co (NYSE: KODK) CEO Jim Continenza said Monday that the company would push ahead with making generic drug ingredients, irrespective of whether it receives government assistance or not, the Wall Street Journal
